WHO ICTRP trial
Safety of Single Aminoglycoside Dose among patient with chronic kidney disease…
ACTRN12625000195459 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12625000195459 |
|---|---|
| Public title | Safety of Single Aminoglycoside Dose among patient with chronic kidney disease in the Emergency Department (SAD-ED). |
| Scientific title | The Occurrence of AKI with Single Aminoglycoside Dose in the Emergency Department (SAD-ED) study in Patients with Chronic Kidney Disease: retrospective cohort study. |
| Primary sponsor | Monash Health |
| Secondary sponsors | Monash Health |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | Chronic Kidney Disease;Sepsis;Acute Kidney Injury; Chronic Kidney Disease Sepsis Acute Kidney Injury;Emergency medicine - Other emergency care;Infection - Studies of infection and infectious agents;Renal and Urogenital - Kidney disease |
| Interventions | This is a retrospective study of all ED patients who have received a single-dose IV aminoglycoside (gentamicin, tobramycin, amikacin) irrespective of the dose given. All data will be extracted of existing medical records. Primary study… |
| Registration date | Feb 20, 2025 |
| Target size | 660 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: